BR9708161A - Peptídeos com aumentada afinidade de ligação para moléculas hla - Google Patents

Peptídeos com aumentada afinidade de ligação para moléculas hla

Info

Publication number: BR9708161A
Authority: BR; Brazil
Prior art keywords: peptides; binding affinity; increased binding; hla molecules; hla
Prior art date: 1996-03-11

Application number

BR9708161A

Other languages

English (en)

Inventor

Alessandro Sette

Robert W Chestnut

John Sidney

Original Assignee

Epimmune Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-11

Filing date

1997-03-10

Publication date

1999-07-27

1997-03-10 Application filed by Epimmune Inc filed Critical Epimmune Inc

1999-07-27 Publication of BR9708161A publication Critical patent/BR9708161A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BR9708161A 1996-03-11 1997-03-10 Peptídeos com aumentada afinidade de ligação para moléculas hla BR9708161A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1311396P	1996-03-11	1996-03-11
PCT/US1997/003778 WO1997033602A1 (en)	1996-03-11	1997-03-10	Peptides with increased binding affinity for hla molecules

Publications (1)

Publication Number	Publication Date
BR9708161A true BR9708161A (pt)	1999-07-27

Family

ID=21758378

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9708161A BR9708161A (pt)	1996-03-11	1997-03-10	Peptídeos com aumentada afinidade de ligação para moléculas hla

Country Status (9)

Country	Link
EP (1)	EP0914142B9 (pt)
JP (2)	JP2001504799A (pt)
CN (1)	CN1225590A (pt)
AT (1)	ATE511849T1 (pt)
AU (1)	AU2203797A (pt)
BR (1)	BR9708161A (pt)
CA (1)	CA2248657A1 (pt)
ES (1)	ES2367640T3 (pt)
WO (1)	WO1997033602A1 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9340577B2 (en)	1992-08-07	2016-05-17	Epimmune Inc.	HLA binding motifs and peptides and their uses
US6183746B1 (en)	1997-10-09	2001-02-06	Zycos Inc.	Immunogenic peptides from the HPV E7 protein
US6013258A (en) *	1997-10-09	2000-01-11	Zycos Inc.	Immunogenic peptides from the HPV E7 protein
JP2002507397A (ja) *	1998-03-13	2002-03-12	エピミューン，インコーポレイティド	Ｈｌａ結合ペプチド及びその使用
AU3215800A (en) *	1999-01-27	2000-08-18	Epimmune, Inc.	Identification of broadly reactive hla restricted t cell epitopes
US20060073150A1 (en)	2001-09-06	2006-04-06	Mary Faris	Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
US7361338B2 (en)	1999-10-05	2008-04-22	Agensys, Inc.	Methods to inhibit growth of prostate cancer cells
CA2386341A1 (en)	1999-11-18	2001-05-25	Epimmune Inc.	Heteroclitic analogs and related methods
US7462354B2 (en)	1999-12-28	2008-12-09	Pharmexa Inc.	Method and system for optimizing minigenes and peptides encoded thereby
AU2002218786A1 (en)	2000-07-12	2002-01-21	Agensys, Inc.	Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
CA2705366A1 (en)	2000-08-28	2002-03-07	Agensys, Inc.	Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
US7459539B2 (en)	2000-12-15	2008-12-02	Agensys, Inc.	Antibody that binds zinc transporter protein 108P5H8
US6924358B2 (en)	2001-03-05	2005-08-02	Agensys, Inc.	121P1F1: a tissue specific protein highly expressed in various cancers
US7271240B2 (en)	2001-03-14	2007-09-18	Agensys, Inc.	125P5C8: a tissue specific protein highly expressed in various cancers
US7736654B2 (en)	2001-04-10	2010-06-15	Agensys, Inc.	Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20030191073A1 (en)	2001-11-07	2003-10-09	Challita-Eid Pia M.	Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
CA2447564A1 (en) *	2001-05-15	2002-11-21	Agensys, Inc.	Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
US7842480B2 (en)	2001-05-18	2010-11-30	Mayo Foundation For Medical Education And Research	Chimeric antigen-specific t cell-activating polypeptides
US20060222656A1 (en)	2005-04-01	2006-10-05	University Of Maryland, Baltimore	MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
JP2005522212A (ja) *	2002-04-05	2005-07-28	エピミューンインコーポレイテッド	ヘテロクリティックアナログおよび関係する方法
JP2005535627A (ja) *	2002-06-25	2005-11-24	シティ・オブ・ホープ	アジュバント不含ペプチド・ワクチン
US20040081653A1 (en)	2002-08-16	2004-04-29	Raitano Arthur B.	Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
JP2006508163A (ja)	2002-11-27	2006-03-09	アジェンシス，インコーポレイテッド	癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質
AU2004210975B2 (en)	2003-02-10	2008-04-10	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
DK1629088T3 (da)	2003-05-30	2012-05-07	Agensys Inc	Varianter af prostatastamcelleantigen (psca) og undersekvenser deraf
JP4651663B2 (ja)	2004-05-28	2011-03-16	アジェンシス，インコーポレイテッド	Ｐｓｃａタンパク質に結合する抗体および関連分子
RU2413735C2 (ru)	2005-03-31	2011-03-10	Эдженсис, Инк.	Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
WO2007083807A1 (ja) *	2006-01-23	2007-07-26	Green Peptide Co., Ltd.	Ｃ型肝炎ウイルス由来ペプチド
WO2007091387A1 (ja)	2006-02-07	2007-08-16	Nec Corporation	Ｈｌａ結合性ペプチド、その前駆体、それをコードするｄｎａ断片および組み換えベクター
EP2085474A4 (en)	2006-10-12	2010-12-01	Nec Corp	HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
CA2991175A1 (en)	2007-11-01	2009-05-07	Mayo Foundation For Medical Education And Research	Hla-dr binding peptides and their uses
EP2391635B1 (en)	2009-01-28	2017-04-26	Epimmune Inc.	Pan-dr binding polypeptides and uses thereof
JP2014516538A (ja) *	2011-05-26	2014-07-17	ジーニウスバイオテクノロジーインベストメンツリミテッドライアビリティカンパニー	調節された免疫優勢療法
IL268919B2 (en)	2017-03-03	2023-10-01	Treos Bio Zrt	A personalized immunogenic peptide identification platform
JP7642530B2 (ja)	2018-09-04	2025-03-10	トレオスバイオリミテッド	ペプチドワクチン
CN116710115A (zh)	2020-11-20	2023-09-05	思维疗法股份有限公司	用于优化的肽疫苗的组合物和方法
US11161892B1 (en)	2020-12-07	2021-11-02	Think Therapeutics, Inc.	Method of compact peptide vaccines using residue optimization
US11421015B2 (en)	2020-12-07	2022-08-23	Think Therapeutics, Inc.	Method of compact peptide vaccines using residue optimization
US11058751B1 (en)	2020-11-20	2021-07-13	Think Therapeutics, Inc.	Compositions for optimized RAS peptide vaccines
US11464842B1 (en)	2021-04-28	2022-10-11	Think Therapeutics, Inc.	Compositions and method for optimized peptide vaccines using residue optimization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5200320A (en) *	1987-12-07	1993-04-06	National Jewish Center For Immunology And Respiratory Medicine	Method for identifying useful polypeptide vaccines
ATE342730T1 (de)	1992-08-07	2006-11-15	Pharmexa Inc	Hla bindepeptide und ihre verwendungen
US20050271676A1 (en) *	1993-03-05	2005-12-08	Epimmune Inc.	Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
ATE227118T1 (de) *	1993-08-02	2002-11-15	Scripps Research Inst	Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
JP3814828B2 (ja) *	1993-10-19	2006-08-30	味の素株式会社	Ｈｉｖに対する免疫応答を誘導できるペプチド及び該ペプチドを含む抗ａｉｄｓ予防・治療剤

1997
- 1997-03-10 AT AT97914975T patent/ATE511849T1/de not_active IP Right Cessation
- 1997-03-10 CA CA002248657A patent/CA2248657A1/en not_active Abandoned
- 1997-03-10 CN CN97194430A patent/CN1225590A/zh active Pending
- 1997-03-10 EP EP97914975A patent/EP0914142B9/en not_active Expired - Lifetime
- 1997-03-10 AU AU22037/97A patent/AU2203797A/en not_active Abandoned
- 1997-03-10 JP JP53275997A patent/JP2001504799A/ja not_active Withdrawn
- 1997-03-10 ES ES97914975T patent/ES2367640T3/es not_active Expired - Lifetime
- 1997-03-10 WO PCT/US1997/003778 patent/WO1997033602A1/en not_active Ceased
- 1997-03-10 BR BR9708161A patent/BR9708161A/pt not_active IP Right Cessation
2008
- 2008-12-24 JP JP2008327605A patent/JP2009108097A/ja active Pending

Also Published As

Publication number	Publication date
EP0914142A1 (en)	1999-05-12
ATE511849T1 (de)	2011-06-15
CN1225590A (zh)	1999-08-11
EP0914142B9 (en)	2012-01-04
WO1997033602A1 (en)	1997-09-18
JP2009108097A (ja)	2009-05-21
EP0914142B1 (en)	2011-06-08
JP2001504799A (ja)	2001-04-10
ES2367640T3 (es)	2011-11-07
EP0914142A4 (en)	2004-06-23
CA2248657A1 (en)	1997-09-18
AU2203797A (en)	1997-10-01

Publication	Publication Date	Title
BR9708161A (pt)	1999-07-27	Peptídeos com aumentada afinidade de ligação para moléculas hla
DE69711083D1 (de)	2002-04-18	Kontaktstift für prüfzwecke
DE69729829D1 (de)	2004-08-19	Zusammensetzung für Wasser-enthaltende Dispersion
WO1999015658A3 (en)	1999-06-10	Human regulatory molecules
DE69818157D1 (de)	2003-10-23	Instrument für Eingriffe am Uterus
BR9703097B1 (pt)	2009-05-05	aparelho para operar o compressor linear.
ATE424560T1 (de)	2009-03-15	Marker für neuromyelitis optica
ATE346922T1 (de)	2006-12-15	Domäne 1 beta2-gpi polypetiden und deren diagnostische und therepeutische verwendungen
DE69005530D1 (de)	1994-02-10	Lüfteranordnung für Wechselstromfahrzeuggenerator.
ATE207949T1 (de)	2001-11-15	Desodoriervorrichtung für fettöle
BR9804676A (pt)	1999-11-23	Processo para o teste de um dispositivo de embreagem automatizado.
DE60026150D1 (de)	2006-04-27	Diagnostika und therapeutika für osteoporose
DE69715430D1 (de)	2002-10-17	Hydrodynamische schmiermitteldichtung für niedrige drehmomente
DE69721506D1 (de)	2003-06-05	Betriebsverfahren für eine ionenfalle
ATE404208T1 (de)	2008-08-15	Uridin-therapie für patienten mit erhöhten purin- werten
DE69625833D1 (de)	2003-02-20	Testkarte für Analysen
BR9808729A (pt)	2000-07-11	Processo para a preparação de um anti-oxidante
DE59005619D1 (de)	1994-06-09	Rollenprüfstand zur kombinierten Leistungs- und Bremsenprüfung an Kraftfahrzeugen.
DK0929299T3 (da)	2004-02-16	Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
DE69732302D1 (de)	2005-02-24	Kompakte vorrichtung für beleuchtung
PT801179E (pt)	2003-10-31	Dispositivo para controlo da valvula de um autoclismo
EP1017716A4 (en)	2001-01-03	Car receptors and related molecules and methods
NO900052L (no)	1990-07-09	Fremgangsmaate for betjening av en oljebroenn til havs.
PT789591E (pt)	2003-08-29	Metodo para identificar individuos que sofram de uma anomalia celular
AR019572A1 (es)	2002-02-27	Procedimiento de adsorcion para la desaromatizacion de hidrocarburos.

Legal Events

Date	Code	Title	Description
2006-07-25	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 5A , 6A , 7A , 8A E 9A ANUIDADES.
2011-12-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1855 DE 25/07/2006.